Silence Therapeutics: Of The Current Report On Form 8k Filed On December 15, 2025 (the “original Form 8k”) To Disclose Information Regarding Material Modifications To A Material Compensatory Plan, Contract Or Arrangement As To Which A Named Executive Officer Of The Registrant Participates That Were Effected Pursuant To An Agreement Entered Into Subsequent To The Filing Of The Original Form 8k. No Other Changes Have Been Made To The Original Form 8k
10 липня 2026
| Показати всю статтю |
|
Цей функціонал доступний лише авторизованим користувачам
|
Емітент —
Silence Therapeutics
-
Повна назваSilence Therapeutics PLC
-
Країна реєстраціїUnited Kingdom
-
ГалузьPharmaceutical Preparation and Biotechnology
-
M/S&P/F
*** /*** /***
Поділитися